Related Experiment Video
Updated: Apr 28, 2026
05:25
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
3.4K
Mortality from chronic liver diseases in diabetes
Giacomo Zoppini1, Ugo Fedeli2, Nicola Gennaro2
1Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Hospital Trust of Verona, Verona, Italy.
The American Journal of Gastroenterology
|June 4, 2014
Summary
Diabetic patients face a significantly higher risk of death from chronic liver diseases (CLDs). This increased mortality is primarily linked to non-virus, non-alcohol-related liver conditions, particularly nonalcoholic fatty liver disease (NAFLD).
Area of Science:
- Hepatology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a known risk factor for increased mortality from chronic liver diseases (CLDs).
- The specific etiologies contributing to CLD mortality in diabetic populations remain under-investigated.
- Understanding these causes is crucial for targeted interventions.
Purpose of the Study:
- To determine the mortality rates from CLD by etiology in diabetic individuals.
- To compare CLD mortality in diabetic subjects to the general population.
- To identify the primary drivers of CLD-related deaths in diabetes.
Main Methods:
- A cohort of 167,621 diabetic subjects (aged 30-89) in the Veneto Region, Italy, was identified in 2007.
- Vital status was tracked from 2008-2010, calculating standardized mortality ratios (SMRs) against regional rates.
- Causes of death were scrutinized, categorizing CLD into virus-related, alcohol-related, and non-virus/non-alcohol-related (primarily NAFLD).
Main Results:
- Diabetic individuals exhibited a 2.47-fold (men) and 2.70-fold (women) increased risk of dying from CLD.
- SMRs for CLD etiologies were 2.17 (virus-related), 2.25 (alcohol-related), and 2.86 (non-virus/non-alcohol-related).
- The non-virus, non-alcohol-related category, largely NAFLD, showed the highest mortality risk in diabetic patients.
Conclusions:
- Diabetic patients have a 2- to 3-fold higher risk of mortality from CLD.
- Non-virus, non-alcohol-related CLD, predominantly NAFLD, is the main driver of this increased risk.
- Early diagnosis and management of NAFLD may improve survival rates in diabetic populations.
Related Concept Videos
01:21Chronic Pancreatitis II: Pathophysiology
26
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
26
01:25Chronic Pancreatitis I: Introduction
25
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
25
01:24Chronic Pancreatitis I: Introduction
903
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
903
01:22Complications of Diabetes Mellitus
17
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
17
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:24Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K